Global Medical Image Analysis Software Market Projected to Grow at a Robust CAGR of 7.9% over the Forecast Period 2016-2024

Without any doubts, automation makes our lives easier.If we look around us, we are surrounded by automatic instruments – from your very basic alarm clock to shopping mall doors and huge robotics integration arms in manufacturing facilities.

Industrial automation has become very essential today where factory robots, robotic arms and industrial motion control can operate your processes 24/7 without taking a break or without any human intervention.

In order to automate industrial equipment, factory automation software solutions are used.

Let’s find out why investing in industrial automation is going to be beneficial, and especially in the time of COVID-19 crisis, when there is a huge demand for consumer goods but restrictions on the number of workers allowed in the factory premise.Reduce number of damaged productThere were higher numbers of damaged goods in earlier times when much of the production was done manually.

It is natural for humans to make mistakes.

But mistakes are going to be very less unless there are component errors or damaging raw materials.Decrease worker exhaustion and labor intensive taskBasically, humans don’t like to do repetitive tasks, but software and machines can!

Global Drug Discovery Informatics Market is expected to show a tremendous growth over the forecast period owing to the technological advancements in the field of data mining and analytics regarding structured and unstructured data explosions, and drug development.

The continuous advancements in software for the endowment of data visualization, data processing and analysis and data aggregation for the adoption of more automated and integrated lab systems.

Furthermore, the lack of informational technology applications that provides critical attributes of data evaluation and assisting in data aggregation so as to make real-time decisions is presumed to influence research in this sector.The significant shift from conventional in-vitro drug development to computer aided drug designing as expensive failures of late drug development upsurges the use of in-silico models for early ADME/Toxicity screening is estimated to boost the growth of this sector.

Moreover, the increasing disease burden due to growing incidence of chronic diseases such as infectious diseases, oncology, cardiovascular and diabetes is considered to be the major concerns for healthcare and government providers across the globe.

Outsourced informatics is estimated to witness the fastest growth over the coming six years owing to the rising collaborations between key players and software service provider so as to gain access to in-silicon databases and tools for the therapeutic drug discovery.

Market HighlightsAccording to MRFR analysis, Organ-On-a-Chip Market is expected to register a CAGR of 53% during the forecast period of 2019 to 2025 and was valued at USD 51.3 Million in 2018.Organs-on-chips (OOCs) are small plastic devices with biocompatible microfluidic chambers, which contain multiple live human cells in a 3D culture that simulate crucial physiological functions of body organs.

These cells are placed in an environment that artificially replicates aspects of the human body, such as morphology, movement, flow, electrical stimuli, and liquid gradients.Request Sample Copy:https://www.marketresearchfuture.com/sample_request/8498The global organ-on-a-chip market is growing owing to various reasons, such as an increase in the number of collaborative sales agreements between pharmaceutical companies and university spin-offs and the availability of advanced models of OOCs in the market.

The Western European market has further been classified as Germany, France, the UK, Italy, Spain, and the rest of Western Europe.

The organ-on-a-chip market in Asia-Pacific has been segmented into Japan, China, India, South Korea, Australia, and the rest of Asia-Pacific.Asia-Pacific is the fastest-growing region in the market.

This is mainly due to the increased application of OOCs for drug screening for the treatment of various chronic diseases and a supportive regulatory framework in Asia-Pacific.

Such favorable factors are expected to boost market growth during the forecast period.The organ-on-a-chip market in the Middle East & Africa has been divided into the Middle East and Africa.SegmentationThe global organ-on-a-chip market has been segmented based on organ type, application, and end-user.The global organ-on-a-chip market has been segregated, based on organ type, into lung-on-chip, heart-on-chip, liver-on-chip, intestine-on-chip, kidney-on-chip, skin-on-chip, blood-brain barrier-on-chip, human-on-chip, and others.The market based on application has been branched into drug discovery, toxicology research, and others.

A product launch is not an easy task by any stretch of the imagination as it involves multiple groups working as a team to churn out the desired results.

Your company might have launched several drugs before but that would not have a huge say in your new venture going smooth.Failures can occur but the key here is to not worry about them and instead learn from them.

We often talk about the success mantras but rarely do we talk about the mistakes that you need to avoid during a product launch.So, here we have listed the three mistakes that you need to definitely avoid while preparing a drug launch.Not thinking about the big pictureOne of the biggest mistakes that you can make is to not think about the big picture right from the beginning.

When it comes to a drug launch, there are innumerable things to keep in mind, like, licensing, target audience, business campaign, marketing strategy, manufacturing speed, product-pitching, and so on.One way to go about the whole process is to focus on just the specific aspects that you feel need the most attention and forget about the rest of the things.

Yes, this can deliver faster results but it can backfire in a huge way in some cases.

Even the smallest of mistakes in neglected areas can jeopardize the whole product launch.Therefore, the right way to go about it is to first identify all the steps involved in the process of product launch and then go through it one-by-one.

According to the new market research report "High-Throughput Screening (HTS) Market by Product (Instruments, Software, Service), Technology (Cell-Based Assays, Label-Free), Application (Drug Discovery, Biochemical Screening, Research), End User (Pharma & Biotech, CROs)- Global Forecast to 2025", published by MarketsandMarkets™, the global High-Throughput Screening Market size is projected to reach USD 26.4 billion by 2025 from USD  15.3  billion in 2020, at a CAGR of 11.5% during the forecast period.Browse in-depth TOC on "High-Throughput Screening (HTS) Market" 432 – Tables 40 – Figures 319 – PagesDownload PDF Brochure: -https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=134981950The HTS Market growth is driven mainly by factors such as increasing R spending by pharmaceutical & biotechnology companies, technological advancements in high-throughput screening market and the availability of government funding & venture capital investments.

Emerging markets and growing applications in life sciences research are also factors expected to provide growth opportunities for players in the market.The consumables segment accounted for the largest share of the product & services segment in the high-throughput screening market in 2019.On the basis type of product & service, the HTS Market is broadly segmented into consumables , instruments, services, and software.

In 2019, consumables accounted for the largest share of the high-throughput screening (HTS) market.

This can primarily be attributed to the wide use of reagents & assay kits in HTS techniques, increasing pharmaceutical R, and rising government funding for life sciences research.The drug discovery segment accounted for the largest share of the application segment in the high-throughput screening market in 2019.Based on application, the HTS Market is categorized into four segments—drug discovery, biochemical screening, life sciences, and other applications.

The drug discovery application segment accounted for the largest share of the market in 2019.

The key factor driving this segments growth is the increasing number of clinical trials and rising pharmaceutical R expenditure.Request Sample Pages:-https://www.marketsandmarkets.com/requestsampleNew.asp?id=134981950The Asia Pacific region is the fastest-growing region of the high-throughput screening market in 2019.In 2019, Asia Pacific region accounted for the fastest-growing region of the HTS Market.